Testing effectiveness (Phase 2)Looking for participantsNCT06482892
What this trial is testing
TP03HN106 in Patients With Critical Limb Ischemia
Who this might be right for
Critical Limb Ischemia
Talengen Institute of Life Sciences, Shenzhen, P.R. China. 15